U.S. Must Help Developing Nations to Boost Import Safety, IOM Says

The FDA and other agencies must provide expertise, training and tools to developing nations to improve their pharma monitoring practices and prevent dangerous drugs and medical products from entering the U.S., according to a new Institute of Medicine (IOM) report. The recommendation is one of 13 suggested steps to strengthen regulatory systems abroad.
Washington Drug Letter